Acknowledgement
This study was supported by the "Korea Disease Control and Prevention Agency, Republic of Korea".
References
- World Health Organization. Global tuberculosis report 2019. Geneva: World Health Organization; 2019.
- Woods GL, Brown-Elliott BA, Conville PS, Desmond EP, Hall GS, Lin G, et al. Susceptibility testing of mycobacteria, Nocardiae, and other aerobic actinomycetes. Report No. M24-A2. Wayne: Clinical and Laboratory Standards Institute; 2011.
- Miotto P, Zhang Y, Cirillo DM, Yam WC. Drug resistance mechanisms and drug susceptibility testing for tuberculosis. Respirology 2018;23:1098-113. https://doi.org/10.1111/resp.13393
- Koh WJ, Ko Y, Kim CK, Park KS, Lee NY. Rapid diagnosis of tuberculosis and multidrug resistance using a MGIT 960 system. Ann Lab Med 2012;32:264-9. https://doi.org/10.3343/alm.2012.32.4.264
- Palomino JC, Martin A, Von Groll A, Portaels F. Rapid culture-based methods for drug-resistance detection in Mycobacterium tuberculosis. J Microbiol Methods 2008;75:161-6. https://doi.org/10.1016/j.mimet.2008.06.015
- O'Grady J, Maeurer M, Mwaba P, Kapata N, Bates M, Hoelscher M, et al. New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis. Curr Opin Pulm Med 2011;17:134-41. https://doi.org/10.1097/MCP.0b013e3283452346
- Wells WA, Boehme CC, Cobelens FG, Daniels C, Dowdy D, Gardiner E, et al. Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action. Lancet Infect Dis 2013;13:449-58. https://doi.org/10.1016/S1473-3099(13)70025-2
- Xie YL, Chakravorty S, Armstrong DT, Hall SL, Via LE, Song T, et al. Evaluation of a rapid molecular drug-susceptibility test for tuberculosis. N Engl J Med 2017;377: 1043-54. https://doi.org/10.1056/NEJMoa1614915
- Zhang Y, Yew WW. Mechanisms of drug resistance in Mycobacterium tuberculosis . Int J Tuberc Lung Dis 2009;13:1320-30.
- Gygli SM, Borrell S, Trauner A, Gagneux S. Antimicrobial resistance in Mycobacterium tuberculosis : mechanistic and evolutionary perspectives. FEMS Microbiol Rev 2017;41:354-73. https://doi.org/10.1093/femsre/fux011
- Norden MA, Kurzynski TA, Bownds SE, Callister SM, Schell RF. Rapid susceptibility testing of Mycobacterium tuberculosis (H37Ra) by flow cytometry. J Clin Microbiol 1995;33:1231-7. https://doi.org/10.1128/jcm.33.5.1231-1237.1995
- Bownds SE, Kurzynski TA, Norden MA, Dufek JL, Schell RF. Rapid susceptibility testing for nontuberculosis mycobacteria using flow cytometry. J Clin Microbiol 1996;34:1386-90. https://doi.org/10.1128/jcm.34.6.1386-1390.1996
- Kirk SM, Schell RF, Moore AV, Callister SM, Mazurek GH. Flow cytometric testing of susceptibilities of Mycobacterium tuberculosis isolates to ethambutol, isoniazid, and rifampin in 24 hours. J Clin Microbiol 1998;36:1568-73. https://doi.org/10.1128/JCM.36.6.1568-1573.1998
- Reis RS, Neves I Jr, Lourenco SL, Fonseca LS, Lourenco MC. Comparison of flow cytometric and Alamar Blue tests with the proportional method for testing susceptibility of Mycobacterium tuberculosis to rifampin and isoniazid. J Clin Microbiol 2004;42:2247-8. https://doi.org/10.1128/JCM.42.5.2247-2248.2004
- Fredricks BA, DeCoster DJ, Kim Y, Sparks N, Callister SM, Schell RF. Rapid pyrazinamide susceptibility testing of Mycobacterium tuberculosis by flow cytometry. J Microbiol Methods 2006;67:266-72. https://doi.org/10.1016/j.mimet.2006.03.020
- DeCoster DJ, Vena RM, Callister SM, Schell RF. Susceptibility testing of Mycobacterium tuberculosis: comparison of the BACTEC TB-460 method and flow cytometric assay with the proportion method. Clin Microbiol Infect 2005;11:372-8. https://doi.org/10.1111/j.1469-0691.2005.01127.x
- Hendon-Dunn CL, Doris KS, Thomas SR, Allnutt JC, Marriott AA, Hatch KA, et al. A flow cytometry method for rapidly assessing Mycobacterium tuberculosis responses to antibiotics with different modes of action. Antimicrob Agents Chemother 2016;60:3869-83. https://doi.org/10.1128/AAC.02712-15
- Goossens SN, Sampson SL, Van Rie A. Mechanisms of drug-induced tolerance in Mycobacterium tuberculosis. Clin Microbiol Rev 2020;34:e00141-20.
- Bellerose MM, Baek SH, Huang CC, Moss CE, Koh EI, Proulx MK, et al. Common variants in the glycerol kinase gene reduce tuberculosis drug efficacy. mBio 2019;10:e0063-19.
- Safi H, Gopal P, Lingaraju S, Ma S, Levine C, Dartois V, et al. Phase variation in Mycobacterium tuberculosis glpK produces transiently heritable drug tolerance. Proc Natl Acad Sci U S A 2019;116:19665-74. https://doi.org/10.1073/pnas.1907631116
- Lim J, Lee JJ, Lee SK, Kim S, Eum SY, Eoh H. Phosphoenolpyruvate depletion mediates both growth arrest and drug tolerance of Mycobacterium tuberculosis in hypoxia. Proc Natl Acad Sci U S A 2021;118:e2105800118. https://doi.org/10.1073/pnas.2105800118